Search Results - "van’t Land, Freek R."

ASO Visual Abstract: Nationwide Use and Outcome of Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy by Stoop, Thomas F., Seelen, Leonard W. F., van’t Land, Freek R., Lutchman, Kishan R. D., van Dieren, Susan, Lips, Daan J., van der Harst, Erwin, Kazemier, Geert, Patijn, Gijs A., de Hingh, Ignace H., Wijsman, Jan H., Erdmann, Joris I., Festen, Sebastiaan, Groot Koerkamp, Bas, Mieog, J. Sven D., Dulk, Marcel den, Stommel, Martijn W. J., Busch, Olivier R., de Wilde, Roeland F., de Meijer, Vincent E., Riele, Wouter te, Molenaar, I. Quintus, van Eijck, Casper H. J., van Santvoort, Hjalmar C., Besselink, Marc G.

Get full text

37 Collagen remodeling biomarkers in patients with locally advanced pancreatic cancer treated with stereotactic body radiotherapy plus intradermal heat-killed mycobacterium obuense (IMM-101) vaccination by Jensen, Christina, Land, Freek R van’t, Karsdal, Morten A, Eijck, Casper HJ van, Willumsen, Nicholas

“…BackgroundPancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers and several clinical trials with new therapies are being conducted in an…”
Get full text

Increasing Systemic Immune-Inflammation Index During Treatment in Patients with Advanced Pancreatic Cancer is Associated with Poor Survival – A Retrospective, Multicenter, Cohort Study by Van ‘t Land, Freek R., Aziz, Mohammad H., Michiels, Nynke, Mieog, J. Sven D., Bonsing, Bert A., Luelmo, Saskia A.C., Homs, Marjolein Y.V., Groot Koerkamp, Bas, Papageorgiou, Grigorios, van Eijck, Casper H.J.

“…A high systemic immune-inflammation index (SIII) at diagnosis of various cancers, including pancreatic cancer, is associated with poor prognosis. The impact of…”
Get full text

Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX – The LAPC-2 trial by van 't Land, Freek R., Latifi, Diba, Moskie, Miranda, Homs, Marjolein Y.V., Bosscha, Koop, Bonsing, Bert A., Mieog, Sven D., van der Harst, Erwin, Coene, Peter-Paul L.O., Wijsman, Jan H., van der Schelling, George P., Groot Koerkamp, Bas, Nuyttens, Joost J., van Eijck, Casper H.J.

“…•The combination treatment of stereotactic body radiotherapy (SBRT) and IMM-101 is safe and feasible for locally advanced pancreatic cancer patients.•Clinical…”
Get full text

Dendritic Cell-Based Immunotherapy in Patients With Resected Pancreatic Cancer by van 't Land, Freek R, Willemsen, Marcella, Bezemer, Koen, van der Burg, Sjoerd H, van den Bosch, Thierry P P, Doukas, Michail, Fellah, Amine, Kolijn, P Martijn, Langerak, Anton W, Moskie, Miranda, van der Oost, Elise, Rozendaal, Nina E M, Baart, Sara J, Aerts, Joachim G J V, van Eijck, Casper H J

“…Immunotherapies have shown limited responses in patients with advanced pancreatic cancer. Recently, we reported that dendritic cell (DC)-based immunotherapy…”
Get full text